Approval · Notice of Compliance 29344 · 2022
OXY.IR: Notice of Compliance 29344
Issued October 31, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29344
- Date
- October 31, 2022
- Company
- Purdue PharmaToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety and administrative updates to the Product Monograph (PM), Patient Medication Information (PMI), Package Insert (PI) and package labels.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OXY.IR | Not yet assigned | — |
Medicinal ingredients
- OXYCODONE HYDROCHLORIDE 5 MG per TAB
- OXYCODONE HYDROCHLORIDE 10 MG per TAB
- OXYCODONE HYDROCHLORIDE 20 MG per TAB